These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 21932599)

  • 1. Structural chromosome disruption of the NR3C2 gene causing pseudohypoaldosteronism type 1 presenting in infancy.
    O'Connell SM; Johnson SR; Lewis BD; Staltari L; Peverall J; Ly T; Martin AC; Jones TW; Price GJ; Murch A; Choong CS
    J Pediatr Endocrinol Metab; 2011; 24(7-8):555-9. PubMed ID: 21932599
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pseudohypoaldosteronism type 1 due to a novel mutation in the mineralocorticoid receptor gene.
    Loomba-Albrecht LA; Nagel M; Bremer AA
    Horm Res Paediatr; 2010; 73(6):482-6. PubMed ID: 20453518
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Neonate with Autosomal Dominant Pseudohypoaldosteronism Type 1 Due to a Novel Microdeletion of the
    Kim SJ; Park D; Jang W; Lee J
    Children (Basel); 2021 Nov; 8(12):. PubMed ID: 34943285
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Renin-aldosterone system evaluation over four decades in an extended family with autosomal dominant pseudohypoaldosteronism due to a deletion in the NR3C2 gene.
    Hanukoglu A; Vargas-Poussou R; Landau Z; Yosovich K; Hureaux M; Zennaro MC
    J Steroid Biochem Mol Biol; 2020 Nov; 204():105755. PubMed ID: 33017655
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical and molecular analysis of six Japanese patients with a renal form of pseudohypoaldosteronism type 1.
    Hatta Y; Nakamura A; Hara S; Kamijo T; Iwata J; Hamajima T; Abe M; Okada M; Ushio M; Tsuyuki K; Tajima T
    Endocr J; 2013; 60(3):299-304. PubMed ID: 23197115
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A case of pseudohypoaldosteronism type 1 with a mutation in the mineralocorticoid receptor gene.
    Lee SE; Jung YH; Han KH; Lee HK; Kang HG; Ha IS; Choi Y; Cheong HI
    Korean J Pediatr; 2011 Feb; 54(2):90-3. PubMed ID: 21503203
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inactivating mutations of the mineralocorticoid receptor in Type I pseudohypoaldosteronism.
    Sartorato P; Khaldi Y; Lapeyraque AL; Armanini D; Kuhnle U; Salomon R; Caprio M; Viengchareun S; Lombès M; Zennaro MC
    Mol Cell Endocrinol; 2004 Mar; 217(1-2):119-25. PubMed ID: 15134810
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mineralocorticoid receptor mutations and a severe recessive pseudohypoaldosteronism type 1.
    Hubert EL; Teissier R; Fernandes-Rosa FL; Fay M; Rafestin-Oblin ME; Jeunemaitre X; Metz C; Escoubet B; Zennaro MC
    J Am Soc Nephrol; 2011 Nov; 22(11):1997-2003. PubMed ID: 21903996
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Mineralocorticoid resistance: pseudohypoaldosteronism type 1].
    Fernandes-Rosa FL; Antonini SR
    Arq Bras Endocrinol Metabol; 2007 Apr; 51(3):373-81. PubMed ID: 17546235
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pseudohypoaldosteronism in a newborn male with functional polymorphisms in the mineralocorticoid receptor genes.
    Jeong HA; Park YK; Jung YS; Nam MH; Nam HK; Lee KH; Rhie YJ
    Ann Pediatr Endocrinol Metab; 2015 Dec; 20(4):230-4. PubMed ID: 26817011
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pseudohypoaldosteronism.
    Riepe FG
    Endocr Dev; 2013; 24():86-95. PubMed ID: 23392097
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel frameshift mutation in NR3C2 leads to decreased expression of mineralocorticoid receptor: a family with renal pseudohypoaldosteronism type 1.
    Kawashima Sonoyama Y; Tajima T; Fujimoto M; Hasegawa A; Miyahara N; Nishimura R; Hashida Y; Hayashi A; Hanaki K; Kanzaki S
    Endocr J; 2017 Jan; 64(1):83-90. PubMed ID: 27725360
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phenotypic diversity and correlation with the genotypes of pseudohypoaldosteronism type 1.
    Gopal-Kothandapani JS; Doshi AB; Smith K; Christian M; Mushtaq T; Banerjee I; Padidela R; Ramakrishnan R; Owen C; Cheetham T; Dimitri P
    J Pediatr Endocrinol Metab; 2019 Sep; 32(9):959-967. PubMed ID: 31301676
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Elucidating the underlying molecular pathogenesis of NR3C2 mutants causing autosomal dominant pseudohypoaldosteronism type 1.
    Riepe FG; Finkeldei J; de Sanctis L; Einaudi S; Testa A; Karges B; Peter M; Viemann M; Grötzinger J; Sippell WG; Fejes-Toth G; Krone N
    J Clin Endocrinol Metab; 2006 Nov; 91(11):4552-61. PubMed ID: 16954160
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mineralocorticoid receptor mutations are the principal cause of renal type 1 pseudohypoaldosteronism.
    Pujo L; Fagart J; Gary F; Papadimitriou DT; Claës A; Jeunemaître X; Zennaro MC
    Hum Mutat; 2007 Jan; 28(1):33-40. PubMed ID: 16972228
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exclusion of the locus for autosomal recessive pseudohypoaldosteronism type 1 from the mineralocorticoid receptor gene region on human chromosome 4q by linkage analysis.
    Chung E; Hanukoglu A; Rees M; Thompson R; Dillon M; Hanukoglu I; Bistritzer T; Kuhnle U; Seckl J; Gardiner RM
    J Clin Endocrinol Metab; 1995 Nov; 80(11):3341-5. PubMed ID: 7593448
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical and molecular features of type 1 pseudohypoaldosteronism.
    Riepe FG
    Horm Res; 2009; 72(1):1-9. PubMed ID: 19571553
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel missense mutation of mineralocorticoid receptor gene in one Japanese family with a renal form of pseudohypoaldosteronism type 1.
    Tajima T; Kitagawa H; Yokoya S; Tachibana K; Adachi M; Nakae J; Suwa S; Katoh S; Fujieda K
    J Clin Endocrinol Metab; 2000 Dec; 85(12):4690-4. PubMed ID: 11134129
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardiovascular effects of aldosterone: insight from adult carriers of mineralocorticoid receptor mutations.
    Escoubet B; Couffignal C; Laisy JP; Mangin L; Chillon S; Laouénan C; Serfaty JM; Jeunemaitre X; Mentré F; Zennaro MC
    Circ Cardiovasc Genet; 2013 Aug; 6(4):381-90. PubMed ID: 23852419
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Complete clinical resolution of a Japanese family with renal pseudohypoaldosteronism type 1 due to a novel NR3C2 mutation.
    Tanaka T; Oki E; Mori T; Tsuruga K; Sohara E; Uchida S; Tanaka H
    Nephrology (Carlton); 2019 Apr; 24(4):489-490. PubMed ID: 30919533
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.